Grufity logoGrufity logo
StocksFundsSearch FilingsAPI

Medifast Inc Stock Research

MED

82.62USD+1.72(+2.13%)Delayedas of 20 Sep 2023, 03:24 pm
Watchlist

Market Summary

USD82.62+1.72
Delayedas of 20 Sep 2023, 03:24 pm
2.13%

MED Alerts

  • 1 major insider sales recently.
  • Big fall in Revenue (Y/Y)

MED Stock Price

MED RSI Chart

MED Valuation

Market Cap

880.9M

Price/Earnings (Trailing)

6.63

Price/Sales (Trailing)

0.64

EV/EBITDA

3.97

Price/Free Cashflow

4.41

MED Price/Sales (Trailing)

MED Profitability

Operating Margin

70.89%

EBT Margin

11.92%

Return on Equity

82.95%

Return on Assets

44.08%

Free Cashflow Yield

22.66%

MED Fundamentals

MED Revenue

Revenue (TTM)

1.4B

Revenue Y/Y

-34.66%

Revenue Q/Q

-15.13%

MED Earnings

Earnings (TTM)

132.9M

Earnings Y/Y

-22.58%

Earnings Q/Q

-24.24%

Price Action

52 Week Range

77.67131.42
(Low)(High)

Last 7 days

-1.3%

Last 30 days

-4.0%

Last 90 days

-4.7%

Trailing 12 Months

-31.1%

MED Financial Health

Current Ratio

1.75

MED Investor Care

Dividend Yield

8.13%

Dividend/Share (TTM)

6.58

Buy Backs (1Y)

4.10%

Diluted EPS (TTM)

12.14

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales

Latest Insider Trading transactions for MED

Filter Transactions
Datesorted ascendingNameBuy/Sell$ ValueAvg. Price# SharesTitle
2023-09-13
MacKenzie Jonathan Barrett
sold (taxes)
-810
81.08
-10.00
vp, finance & cao
2023-08-15
BROWN JEFFREY J
sold
-2,088,780
90.1814
-23,162
-
2023-08-14
BROWN JEFFREY J
sold
-1,403,260
92.6
-15,154
-
2023-08-08
SCHLACKMAN SCOTT
bought
3,561
89.42
39.824
-
2023-08-08
BROWN JEFFREY J
bought
3,947
89.42
44.141
-
2023-08-08
Hoer Michael A.
bought
3,366
89.42
37.644
-
2023-08-08
Thomas Andrea B
bought
3,408
89.42
38.115
-
2023-08-04
BROWN JEFFREY J
bought
62,195
100
621
-
2023-08-04
BROWN JEFFREY J
bought
6,713
100
67.119
-
2023-07-20
Maloney James P.
acquired
-
-
3,574
chief financial officer

1–10 of 50

Which funds bought or sold MED recently?

View All Details
Datesorted ascendingFund NameType% Chg$ Change$ Held% Portfolio
2023-09-12
Farther Finance Advisors, LLC
unchanged
-
-219
1,751
-%
2023-09-08
TUCKER ASSET MANAGEMENT LLC
unchanged
-
-1,163
9,308
-%
2023-08-23
Dean Capital Management
added
10.1
-24,094
1,110,160
1.48%
2023-08-22
VIRGINIA RETIREMENT SYSTEMS ET AL
added
35.71
239,728
1,400,830
0.01%
2023-08-21
TEACHERS RETIREMENT SYSTEM OF THE STATE OF KENTUCKY
added
5.69
-22,000
330,000
-%
2023-08-21
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM
reduced
-3.88
-205,876
1,208,490
-%
2023-08-21
OSAIC HOLDINGS, INC.
reduced
-16.91
-104,724
302,327
-%
2023-08-18
Legato Capital Management LLC
added
18.31
80,329
1,632,060
0.22%
2023-08-16
Bridge City Capital, LLC
added
41.93
307,950
1,484,600
0.70%
2023-08-16
Nuveen Asset Management, LLC
added
0.57
-905,282
7,634,720
-%

1–10 of 42

Latest Funds Activity

Are funds buying MED calls or puts?
Calls
Puts
No. of funds holding Calls - Puts
Net Call Options
No. of funds that own MED
No. of Funds

Schedule 13G FIlings of Medifast

Date FiledName of FilerPercent of ClassNo. of SharesForm Type
Feb 13, 2023
renaissance technologies llc
5.78%
632,110
SC 13G/A
Feb 09, 2023
vanguard group inc
15.35%
1,676,883
SC 13G/A
Jan 26, 2023
blackrock inc.
16.9%
1,847,773
SC 13G/A
Jan 20, 2023
blackrock inc.
16.9%
1,847,773
SC 13G/A
Feb 11, 2022
renaissance technologies llc
6.87%
797,610
SC 13G/A
Feb 10, 2022
vanguard group inc
12.91%
1,499,306
SC 13G/A
Jan 27, 2022
blackrock inc.
17.2%
1,995,911
SC 13G/A
Jan 26, 2022
blackrock inc.
17.2%
1,995,911
SC 13G/A
Mar 10, 2021
vanguard group inc
10.68%
1,257,265
SC 13G/A
Feb 16, 2021
miller value partners, llc
0.00%
0
SC 13G/A

Recent SEC filings of Medifast

View All Filings
Date Filed Form Type Document
Sep 15, 2023
4
Insider Trading
Sep 07, 2023
8-K
Current Report
Aug 16, 2023
4
Insider Trading
Aug 14, 2023
144
Notice of Insider Sale Intent
Aug 10, 2023
4
Insider Trading
Aug 10, 2023
4
Insider Trading
Aug 10, 2023
4
Insider Trading
Aug 10, 2023
4
Insider Trading
Aug 10, 2023
4
Insider Trading
Aug 07, 2023
10-Q
Quarterly Report

Peers (Alternatives to Medifast)

View All Peers In Detail
NameMkt Capsorted ascendingRevenuePrice %, 1MReturns, 1YP/EP/SRev 1-YrInc 1-Yr
LARGE-CAP
357.9B
82.0B
0.69% 12.10%
25.07
4.46
2.27% -0.60%
63.2B
18.7B
-1.78% -3.04%
35.42
3.52
5.51% -22.99%
54.4B
15.9B
-2.99% -37.10%
53.87
3.42
-10.30% -58.06%
48.5B
20.4B
-3.02% 1.26%
24.55
2.39
1.47% -8.06%
17.1B
7.4B
-10.02% -2.31%
115.04
2.32
3.97% -67.75%
MID-CAP
9.8B
5.6B
1.68% 46.68%
19.25
1.76
4.71% 95.84%
6.1B
672.6M
-4.71% 184.69%
61.19
9.1
61.02% 257.75%
5.4B
1.6B
6.25% 68.74%
35.01
3.41
18.10% 162.61%
4.5B
1.2B
6.42% 75.08%
30.3
3.68
25.12% 47.03%
2.0B
2.3B
3.74% 1.21%
16.74
0.87
3.51% 7.43%
SMALL-CAP
1.2B
947.8M
-5.86% -1.13%
18.15
1.21
-12.16% -28.99%
880.9M
1.4B
-3.98% -31.07%
6.63
0.64
-17.41% -15.28%
35.2M
10.4M
1.59% -37.75%
15.72
3.39
-27.57% -39.04%

Medifast News

msnNOW
Are These Consumer Staples Too Cheap for Investors To Ignore?.
msnNOW,
2 hours ago
Yahoo Finance
The Motley Fool

Returns for MED

Cumulative Returns on MED

13.9%


10-Year Cumulative Returns

14.2%


7-Year Cumulative Returns

-15.7%


5-Year Cumulative Returns

-21.0%


3-Year Cumulative Returns

Risks for MED

What is the probability of a big loss on MED?

98.8%


Probability that Medifast stock will be more than 20% underwater in next one year

89.6%


Probability that Medifast stock will be more than 30% underwater in next one year.

82.3%


Probability that Medifast stock will be more than 40% underwater in next one year.
*Calculated based on probability distribution of losses observed in actual data in the last 5 years.

How does MED drawdown profile look like?

Y-axis is the maximum loss one would have experienced if Medifast was unfortunately bought at previous high price.

Drawdowns

Financials for Medifast

Income Statement (Last 12 Months)
(In Millions)
Income Statement (Last 12 Months)
(In Millions)
(*) denotes actual numbers (not divided by Millions)
Description(%) Q/Q2023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q12018Q42018Q32018Q2
Revenue-10.3%1,3731,5301,5991,6391,6621,6031,5261,4131,2711,097935841759726714689638568501433371
Cost Of Revenue-10.4%39944545845445342239836532628623721419417917717115613812110390.00
Gross Profit-10.2%9741,0851,1401,1851,2091,1811,1281,049946811698627566547537518482430380330281
  S&GA Expenses-11.2%8019019569861,003963911841749648564512475457446426393351311271229
EBITDA-100.0%-19419520921522622321420216813912510099.00100------
EBITDA Margin-100.0%-0.13*0.12*0.13*0.13*0.14*0.15*0.15*0.16*0.15*0.15*0.15*0.13*0.14*0.14*------
Earnings Before Taxes-5.3%17318218419820621821620719716313411591.0091.0092.0094.0091.0081.0071.0060.0053.00
EBT Margin-100.0%-0.12*0.12*0.12*0.12*0.14*0.14*0.15*0.15*0.15*0.14*0.14*0.12*0.13*0.13*------
Net Income-6.2%13314214415115716516415815012510395.0076.0076.0078.0074.0072.0064.0056.0047.0040.00
Net Income Margin-100.0%-0.09*0.09*0.09*0.09*0.10*0.11*0.11*0.12*0.11*0.11*0.11*0.10*0.10*0.11*------
Free Cashflow-100.0%-19917811668.0040.0060.0097.0013017413914011872.0074.00------
Balance Sheet
(In Millions)
Balance Sheet
(In Millions)
(*) denotes actual numbers (not divided by Millions)
Description(%) Q/Q2023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q12018Q42018Q32018Q2
Assets-0.9%319322316326341421398371364326276261232202195199213210169174156
  Current Assets-0.7%229230223230243324307301304282234217191161154158172169146152135
    Cash Equivalents19.1%14712488.0070.0061.0011810415519220616415613191.0077.0081.0096.0010281.0082.0081.00
  Inventory-28.9%69.0097.0011914515718918013096.0062.0053.0042.0039.0048.0049.0052.0048.0043.0039.0044.0027.00
  Net PPE-2.8%54.0056.0057.0058.0059.0058.0056.0046.0037.0031.0028.0027.0025.0025.0026.0026.0025.0023.0020.0019.0018.00
Liabilities-11.6%13315116117621120519617517015211912111591.0090.0087.0087.0088.0060.0063.0053.00
  Current Liabilities-12.8%11513214115418818117016115414511111210782.0079.0078.0076.0077.0060.0063.0053.00
Shareholder's Equity8.6%186171155151129216202196195175157140117111105111126122109112103
  Retained Earnings7.9%164152140132129203190183185179154140119110169163156143131125117
  Additional Paid-In Capital13.2%22.0019.0022.0019.00-13.0012.0013.0011.009.008.005.003.000.00-12.0011.0010.009.008.007.00
Shares Outstanding0.0%11.0011.0011.0011.0011.0012.0012.0012.0012.0012.0012.0012.0012.0012.0012.0012.0012.0012.0012.0012.0012.00
Cashflow (Last 12 Months)
(In Millions)
Cashflow (Last 12 Months)
(In Millions)
(*) denotes actual numbers (not divided by Millions)
Description(%) Q/Q2023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q12018Q42018Q32018Q2
Cashflow From Operations-0.3%21421519513596.0073.0095.0012214718414514512178.0084.0080.0069.0076.0061.0055.0061.00
  Share Based Compensation-3.7%9.009.0011.0011.0011.0010.0010.009.009.008.007.005.004.005.005.004.004.003.003.003.004.00
Cashflow From Investing-24.9%-14.69-11.76-11.41-13.97-22.59-29.95-29.06-16.87-8.75-2.87-1.28-2.69-1.37-2.18-6.33-5.88-5.03-4.56-1.20-0.61-2.16
Cashflow From Financing42.7%-113-197-199-206-204-131-125-107-77.29-65.62-57.14-66.54-85.41-87.25-82.32-75.68-49.23-56.10-53.33-43.01-41.23
  Dividend Payments-1.5%73.0074.0072.0071.0069.0067.0064.0060.0057.0053.0053.0049.0044.0040.0035.0032.0029.0026.0023.0021.0019.00
  Buy Backs-91.7%10.0012012613015658.0056.0046.0020.0010.005.00-46.00-33.0066.0020.00-30.00-40.00

MED Income Statement

2023-06-30
CONDENSED CONSOLIDATED STATEMENTS OF INCOME (UNAUDITED) - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Income Statement [Abstract]    
Revenue$ 296,188$ 453,333$ 645,170$ 870,933
Cost of sales85,473131,651188,065246,965
Gross profit210,715321,682457,105623,968
Selling, general, and administrative172,009272,718364,887519,917
Income from operations38,70648,96492,218104,051
Other income (expense)    
Interest income (expense)462(164)281(259)
Other expense(51)(4)(53)(20)
Total other (expense) income411(168)228(279)
Income from operations before income taxes39,11748,79692,446103,772
Provision for income taxes8,8379,68322,19822,878
Net income$ 30,280$ 39,113$ 70,248$ 80,894
Earnings per share    
Basic (in usd per share)$ 2.78$ 3.44$ 6.46$ 7.06
Diluted (in usd per share)$ 2.77$ 3.42$ 6.43$ 7.01
Weighted average shares outstanding    
Basic (in shares)10,88811,35410,87611,455
Diluted (in shares)10,91711,43510,92311,534
Cash dividends declared per share (in usd per share)$ 1.65$ 1.64$ 3.30$ 3.28

MED Balance Sheet

2023-06-30
CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED) - USD ($)
$ in Thousands
Jun. 30, 2023
Dec. 31, 2022
Current Assets  
Cash and cash equivalents$ 147,405$ 87,691
Inventories68,896118,856
Prepaid expenses and other current assets12,51616,237
Total current assets228,817222,784
Property, plant and equipment - net of accumulated depreciation54,41257,185
Right-of-use assets16,69918,460
Other assets14,26912,456
Deferred tax assets4,5285,328
TOTAL ASSETS318,725316,213
Current Liabilities  
Accounts payable and accrued expenses105,188134,690
Income taxes payable4,302428
Current lease obligations5,4055,776
Total current liabilities114,895140,894
Lease obligations, net of current lease obligations18,26920,275
Total liabilities133,164161,169
Stockholders' Equity  
Common stock, par value $0.001 per share: 20,000 shares authorized; 10,889 and 10,928 issued and 10,889 and 10,873 outstanding at June 30, 2023 and December 31, 2022, respectively1111
Additional paid-in capital21,54221,555
Accumulated other comprehensive income12324
Retained earnings163,885139,852
Less: treasury stock at cost, 0 and 54 shares at June 30, 2023 and December 31, 2022, respectively0(6,398)
Total stockholders' equity185,561155,044
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY$ 318,725$ 316,213
Daniel R. Chard
980
Medifast, Inc., through its subsidiaries, manufactures and distributes weight loss, weight management, healthy living products, and other consumable health and nutritional products in the United States and the Asia-Pacific. The company offers bars, bites, pretzels, puffs, cereal crunch, drinks, hearty choices, oatmeal, pancakes, pudding, soft serves, shakes, smoothies, soft bakes, and soups under the OPTAVIA, Optimal Health by Take Shape for Life, and Flavors of Home brands. It markets its products through point-of-sale transactions over ecommerce platform. The company was founded in 1980 and is headquartered in Baltimore, Maryland.